1
|
De San Nicolas N, Asokan A, Rosa RD, Voisin SN, Travers MA, Rocha G, Dantan L, Dorant Y, Mitta G, Petton B, Charrière GM, Escoubas JM, Boulo V, Pouzadoux J, Meudal H, Loth K, Aucagne V, Delmas AF, Bulet P, Montagnani C, Destoumieux-Garzón D. Functional Diversification of Oyster Big Defensins Generates Antimicrobial Specificity and Synergy against Members of the Microbiota. Mar Drugs 2022; 20:md20120745. [PMID: 36547892 PMCID: PMC9786018 DOI: 10.3390/md20120745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2022] [Revised: 11/18/2022] [Accepted: 11/22/2022] [Indexed: 11/29/2022] Open
Abstract
Big defensins are two-domain antimicrobial peptides (AMPs) that have highly diversified in mollusks. Cg-BigDefs are expressed by immune cells in the oyster Crassostrea gigas, and their expression is dampened during the Pacific Oyster Mortality Syndrome (POMS), which evolves toward fatal bacteremia. We evaluated whether Cg-BigDefs contribute to the control of oyster-associated microbial communities. Two Cg-BigDefs that are representative of molecular diversity within the peptide family, namely Cg-BigDef1 and Cg-BigDef5, were characterized by gene cloning and synthesized by solid-phase peptide synthesis and native chemical ligation. Synthetic peptides were tested for antibacterial activity against a collection of culturable bacteria belonging to the oyster microbiota, characterized by 16S sequencing and MALDI Biotyping. We first tested the potential of Cg-BigDefs to control the oyster microbiota by injecting synthetic Cg-BigDef1 into oyster tissues and analyzing microbiota dynamics over 24 h by 16S metabarcoding. Cg-BigDef1 induced a significant shift in oyster microbiota β-diversity after 6 h and 24 h, prompting us to investigate antimicrobial activities in vitro against members of the oyster microbiota. Both Cg-BigDef1 and Cg-BigDef5 were active at a high salt concentration (400 mM NaCl) and showed broad spectra of activity against bacteria associated with C. gigas pathologies. Antimicrobial specificity was observed for both molecules at an intra- and inter-genera level. Remarkably, antimicrobial spectra of Cg-BigDef1 and Cg-BigDef5 were complementary, and peptides acted synergistically. Overall, we found that primary sequence diversification of Cg-BigDefs has generated specificity and synergy and extended the spectrum of activity of this peptide family.
Collapse
Affiliation(s)
- Noémie De San Nicolas
- IHPE, University Montpellier, CNRS, Ifremer, University Perpignan Via Domitia, 34090 Montpellier, France
| | - Aromal Asokan
- Centre de Biophysique Moléculaire UPR4301 CNRS, 45071 Orléans, France
| | - Rafael D. Rosa
- Laboratory of Immunology Applied to Aquaculture, Department of Cell Biology, Embryology and Genetics, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil
| | | | - Marie-Agnès Travers
- IHPE, University Montpellier, CNRS, Ifremer, University Perpignan Via Domitia, 34090 Montpellier, France
| | - Gustavo Rocha
- Laboratory of Immunology Applied to Aquaculture, Department of Cell Biology, Embryology and Genetics, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil
| | - Luc Dantan
- IHPE, University Montpellier, CNRS, Ifremer, University Perpignan Via Domitia, 34090 Montpellier, France
| | - Yann Dorant
- IHPE, University Montpellier, CNRS, Ifremer, University Perpignan Via Domitia, 34090 Montpellier, France
| | - Guillaume Mitta
- IHPE, University Montpellier, CNRS, Ifremer, University Perpignan Via Domitia, 34090 Montpellier, France
- Ifremer, IRD, ILM, Université de Polynésie Française, UMR EIO, Vairao 98179, French Polynesia
| | - Bruno Petton
- Ifremer, CNRS, IRD, Ifremer, LEMAR UMR 6539, Université de Bretagne Occidentale, 29840 Argenton-en-Landunvez, France
| | - Guillaume M. Charrière
- IHPE, University Montpellier, CNRS, Ifremer, University Perpignan Via Domitia, 34090 Montpellier, France
| | - Jean-Michel Escoubas
- IHPE, University Montpellier, CNRS, Ifremer, University Perpignan Via Domitia, 34090 Montpellier, France
| | - Viviane Boulo
- IHPE, University Montpellier, CNRS, Ifremer, University Perpignan Via Domitia, 34090 Montpellier, France
| | - Juliette Pouzadoux
- IHPE, University Montpellier, CNRS, Ifremer, University Perpignan Via Domitia, 34090 Montpellier, France
| | - Hervé Meudal
- Centre de Biophysique Moléculaire UPR4301 CNRS, 45071 Orléans, France
| | - Karine Loth
- Centre de Biophysique Moléculaire UPR4301 CNRS, 45071 Orléans, France
- UFR ST, Université d’Orléans, 45067 Orléans, France
| | - Vincent Aucagne
- Centre de Biophysique Moléculaire UPR4301 CNRS, 45071 Orléans, France
| | - Agnès F. Delmas
- Centre de Biophysique Moléculaire UPR4301 CNRS, 45071 Orléans, France
| | - Philippe Bulet
- Plateforme BioPark d’Archamps, Archparc, 74160 Archamps, France
- CR UGA, IAB, INSERM U1209, CNRS UMR5309, 74160 La Tronche-Archamps, France
| | - Caroline Montagnani
- IHPE, University Montpellier, CNRS, Ifremer, University Perpignan Via Domitia, 34090 Montpellier, France
| | - Delphine Destoumieux-Garzón
- IHPE, University Montpellier, CNRS, Ifremer, University Perpignan Via Domitia, 34090 Montpellier, France
- Correspondence: ; Tel.: +33-467144625
| |
Collapse
|
2
|
Balta MG, Schreurs O, Hansen TV, Tungen JE, Vik A, Glaab E, Küntziger TM, Schenck K, Baekkevold ES, Blix IJS. Expression and function of resolvin RvD1 n-3 DPA receptors in oral epithelial cells. Eur J Oral Sci 2022; 130:e12883. [PMID: 35808844 PMCID: PMC9544308 DOI: 10.1111/eos.12883] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2022] [Accepted: 06/08/2022] [Indexed: 11/28/2022]
Abstract
Chronic inflammatory responses can inflict permanent damage to host tissues. Specialized pro‐resolving mediators downregulate inflammation but also can have other functions. The aim of this study was to examine whether oral epithelial cells express the receptors FPR2/ALX and DRV1/GPR32, which bind RvD1n‐3 DPA, a recently described pro‐resolving mediator derived from omega‐3 docosapentaenoic acid (DPA), and whether RvD1n‐3 DPA exposure induced significant responses in these cells. Gingival biopsies were stained using antibodies to FPR2/ALX and DRV1/GPR32. Expression of FPR2/ALX and DRV1/GPR32 was examined in primary oral epithelial cells by qRT‐PCR, flow cytometry, and immunofluorescence. The effect of RvD1n‐3 DPA on intracellular calcium mobilization and transcription of beta‐defensins 1 and 2, and cathelicidin was evaluated by qRT‐PCR. FPR2/ALX and DRV1/GPR32 were expressed by gingival keratinocytes in situ. In cultured oral epithelial cells, FPR2/ALX was detected on the cell surface, whereas FPR2/ALX and DRV1/GPR32 were detected intracellularly. Exposure to RvD1n‐3 DPA induced intracellular calcium mobilization, FPR2/ALX internalization, DRV1/GPR32 translocation to the nucleus, and significantly increased expression of genes coding for beta‐defensin 1, beta‐defensin 2, and cathelicidin. This shows that the signal constituted by RvD1n‐3 DPA is recognized by oral keratinocytes and that this can strengthen the antimicrobial and regulatory potential of the oral epithelium.
Collapse
Affiliation(s)
- Maria G Balta
- Institute of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway
| | - Olav Schreurs
- Institute of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway
| | - Trond V Hansen
- Department of Pharmacy, Section for Pharmaceutical Chemistry, University of Oslo, Norway
| | - Jørn E Tungen
- Department of Pharmacy, Section for Pharmaceutical Chemistry, University of Oslo, Norway
| | - Anders Vik
- Department of Pharmacy, Section for Pharmaceutical Chemistry, University of Oslo, Norway
| | - Enrico Glaab
- Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Luxembourg
| | - Thomas M Küntziger
- Institute of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway
| | - Karl Schenck
- Institute of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway
| | - Espen S Baekkevold
- Institute of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway.,Department of Pathology, Oslo University Hospital and University of Oslo, Oslo, Norway
| | - Inger Johanne S Blix
- Institute of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway.,Department of Periodontology, Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo, Oslo, Norway
| |
Collapse
|
3
|
Abstract
Defensins are short, rapidly evolving, cationic antimicrobial host defence peptides with a repertoire of functions, still incompletely realised, that extends beyond direct microbial killing. They are released or secreted at epithelial surfaces, and in some cases, from immune cells in response to infection and inflammation. Defensins have been described as endogenous alarmins, alerting the body to danger and responding to inflammatory signals by promoting both local innate and adaptive systemic immune responses. However, there is now increasing evidence that they exert variable control on the response to danger; creating a dichotomous response that can suppress inflammation in some circumstances but exacerbate the response to danger and damage in others and, at higher levels, lead to a cytotoxic effect. Focussing in this review on human β-defensins, we discuss the evidence for their functions as proinflammatory, immune activators amplifying the response to infection or damage signals and/or as mediators of resolution of damage, contributing to a return to homeostasis. Finally, we consider their involvement in the development of autoimmune diseases.
Collapse
Affiliation(s)
- Jennifer R Shelley
- Centre for Inflammation Research, The University of Edinburgh, Edinburgh BioQuarter, Edinburgh, Scotland
| | - Donald J Davidson
- Centre for Inflammation Research, The University of Edinburgh, Edinburgh BioQuarter, Edinburgh, Scotland
| | - Julia R Dorin
- Centre for Inflammation Research, The University of Edinburgh, Edinburgh BioQuarter, Edinburgh, Scotland
| |
Collapse
|
4
|
Jarczak J, Kościuczuk EM, Lisowski P, Strzałkowska N, Jóźwik A, Horbańczuk J, Krzyżewski J, Zwierzchowski L, Bagnicka E. Defensins: natural component of human innate immunity. Hum Immunol 2013; 74:1069-79. [PMID: 23756165 DOI: 10.1016/j.humimm.2013.05.008] [Citation(s) in RCA: 119] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2012] [Revised: 04/23/2013] [Accepted: 05/29/2013] [Indexed: 12/19/2022]
Abstract
The widespread use of antibiotics has contributed to a huge increase in the number of resistant bacteria. New classes of drugs are therefore being developed of which defensins are a potential source. Defensins are a group of antimicrobial peptides found in different living organisms, involved in the first line of defense in their innate immune response against pathogens. This review summarizes the results of studies of this family of human antimicrobial peptides (AMPs). There is a special emphasis on describing the entire group and individual peptides, history of their discovery, their functions and expression sites. The results of the recent studies on the use of the biologically active peptides in human medicine are also presented. The pharmaceutical potential of human defensins cannot be ignored, especially considering their strong antimicrobial activity and properties such as low molecular weight, reduced immunogenicity, broad activity spectrum and resistance to proteolysis, but there are still many challenges and questions regarding the possibilities of their practical application.
Collapse
|